Search results for "Drug-naïve"

showing 5 items of 5 documents

Disturbed brain activation during a working memory task in drug-naive adult patients with ADHD.

2010

Neuroimaging studies in attention-deficit/hyperactivity disorder (ADHD) have shown abnormalities in several brain areas including the frontostriatal circuitry and were mostly conducted in children and adolescents. We investigated 30 never-medicated adult ADHD patients (16 males) and 30 matched healthy control individuals. Functional magnetic resonance imaging was acquired during a working memory paradigm (n-back). Group activation maps and group differences of activation were calculated using voxel-based analyses. The generic activation pattern was more extended in the control group. In ADHD patients, significantly decreased activation was found in the right inferior parietal cortex. Distur…

AdultMaleAdolescentCentral nervous systemPosterior parietal cortexYoung AdultNeuroimagingmental disordersmedicineAttention deficit hyperactivity disorderHumansMemory Disordersmedicine.diagnostic_testWorking memoryIllicit DrugsGeneral NeuroscienceBrainCognitionMiddle Agedmedicine.diseaseDrug-naïvemedicine.anatomical_structureMemory Short-TermAttention Deficit Disorder with HyperactivityFemalePsychologyFunctional magnetic resonance imagingNeurosciencemedicine.drugNeuroreport
researchProduct

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive …

2012

Background: The effect of drug resistance transmission on disease progression in the newly infected patient is not well understood. Major drug resistance mutations severely impair viral fitness in a drug free environment, and therefore expected to revert quickly. Compensatory mutations, often already polymorphic in wild-type viruses, do not tend to revert after transmission. While compensatory mutations increase fitness during treatment, their presence may also modulate viral fitness and virulence in absence of therapy and major resistance mutations. We previously designed a modeling technique that quantifies genotypic footprints of in vivo treatment selective pressure, including both drug …

AdultMalelcsh:Immunologic diseases. AllergyAnti-HIV AgentseducationVirulenceHIV InfectionsDrug resistanceBiologySettore MED/42 - Igiene Generale E ApplicataViruspolymorphism03 medical and health sciencesViral ProteinsSDG 3 - Good Health and Well-beingVirologyGenotypeDrug Resistance Viraldrug-naivemedicineHumansProspective Studies030304 developmental biology0303 health sciencesPolymorphism Genetic030306 microbiologyResearchproteaseViral LoadVirologyReverse transcriptase3. Good healthCD4 Lymphocyte CountDrug-naïveInfectious Diseases3121 General medicine internal medicine and other clinical medicineImmunologybiology.proteinHIV-1FemaleAntibodylcsh:RC581-607Viral loadHIV-1 infected patientmedicine.drugPeptide HydrolasesRetrovirology
researchProduct

Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study

2012

Identification of predictors of cardiovascular risk can help in the prevention of pathologic episodes and the management of patients at all stages of illness. Here, we investigated the relationships between serum levels of Hsp60 and dyslipidemia in patients with periodontitis by performing a cross-sectional study of 22 patients with mild periodontitis without any prior treatment for it (i.e., drug naive) and 22 healthy controls, matched for age and body mass index (BMI). All subjects were evaluated for periodontal status, gingival inflammation, and oral hygiene. Levels of circulating Hsp60, C-reactive protein (CRP), and plasma lipids were measured, and small, dense low-density lipoproteins …

AdultMalemedicine.medical_specialtyPeriodontal pathologyPilot ProjectsBiochemistryBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansperiodontitisTriglyceridesDyslipidemiasPeriodontitisOriginal PaperbiologyCholesterolbusiness.industrydyslipidemiaC-reactive proteinAge FactorsMouth MucosaChaperonin 60Cell BiologyMiddle AgedHsp60medicine.diseaseLipidsHsp60; dyslipidemia; periodontitisLipoproteins LDLDrug-naïveC-Reactive ProteinCross-Sectional StudiesEndocrinologychemistryCardiovascular Diseasesbiology.proteinFemaleMetabolic syndromeLipoproteins HDLbusinessBody mass indexDyslipidemiamedicine.drugCell Stress and Chaperones
researchProduct

Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes

2020

Metformin is the first-line pharmacotherapy for managing type 2 diabetes (T2D). However, many patients with T2D do not respond to or tolerate metformin well. Currently, there are no phenotypes that successfully predict glycemic response to, or tolerance of, metformin. We explored whether blood-based epigenetic markers could discriminate metformin response and tolerance by analyzing genome-wide DNA methylation in drug-naïve patients with T2D at the time of their diagnosis. DNA methylation of 11 and 4 sites differed between glycemic responders/nonresponders and metformin-tolerant/intolerant patients, respectively, in discovery and replication cohorts. Greater methylation at these sites associ…

Blood Glucose0301 basic medicineOncologymedicine.medical_specialtyendocrine system diseases030209 endocrinology & metabolismType 2 diabetesEpigenesis Genetic03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsEpigeneticsGlycemicbusiness.industrynutritional and metabolic diseasesGeneral MedicineOdds ratioDNA Methylationmedicine.diseaseMetformin3. Good healthMetforminDrug-naïve030104 developmental biologyDiabetes Mellitus Type 2Pharmaceutical PreparationsDNA methylationbusinessmedicine.drugScience Translational Medicine
researchProduct

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration fi…

2016

BACKGROUND Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions. MATERIAL AND METHODS The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naive MDD pa…

medicine.medical_specialtybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersmedicinePsychiatryGeneral DentistryFirst episodebusiness.industryResearchHamilton Rating Scale for Depressionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive Dentistry030227 psychiatryDrug-naïveDistressstomatognathic diseasesUNESCO::CIENCIAS MÉDICASMajor depressive disorderAnxietymedicine.symptombusiness030217 neurology & neurosurgeryState-Trait Anxiety Inventorymedicine.drugPsychopathologyJournal of clinical and experimental dentistry
researchProduct